Skip to content
value.today

CDT Equity Inc.

CDT
$0 Mmarket cap on Oct 30, 2026
Compare
World rank
#28,325
Revenue
—
For year ending December-2025
Net income
$-39 M
SEC filing
Employees
—

CDT Equity Inc. in brief

CDT Equity Inc. is a listed company in the Biotechnology industry, based in Naples, Florida, USA. Its market value was $0 M on 30 October 2026, which makes it the 28,325th largest listed company in the world and the 4,528th largest in the USA on this site. Its shares trade under the symbol CDT (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About CDT Equity Inc.

CDT Equity Inc., formerly Conduit Pharmaceuticals Inc., a Delaware corporation, is a data-driven pharmaceutical development, focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. The Company has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments.

The Company’s strategy is centered on unlocking the untapped value of clinical-stage compounds, particularly those deprioritized by larger pharmaceutical companies with strong, supporting Phase I safety data. Through advanced co-crystallization and solid-form technologies developed at our Cambridge facilities, the Company improves drug properties and extends patent life by up to 20 years. In partnership with Sarborg Limited, the Company also applies AI-powered signature analysis to rapidly identify new therapeutic applications and combinations for existing compounds.

From the company's annual report filed with the US SEC: read the report

CDT Equity Inc. timeline

3 events, 2021–2025
  1. 2021
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2023
  4. ✎
    Renamed Conduit Pharmaceuticals Inc.
    Formerly Murphy Canyon Acquisition Corp..
  5. 2025
  6. ✎
    Renamed CDT Equity Inc.
    Formerly Conduit Pharmaceuticals Inc..

Events of CDT Equity Inc. from SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$0 M$0 M$1 M$1 M

World rank over time

▼ down 66 places since 2026
2026-10-09: #28265#28,26520262026-10-30: #28331#28,3312026

Rank in USA: #4,516 (Oct 2026) · #4,531 (Oct 2026)

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2022: revenue —, net income $-5M—FY22Fiscal year ending Dec 2023: revenue —, net income $-1M—FY23Fiscal year ending Dec 2024: revenue —, net income $-18M—FY24Fiscal year ending Dec 2025: revenue —, net income $-39M—FY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025——$-37M$-39M—
Dec 2024——$-15M$-18M—
Dec 2023——$-5M$-1M—
Dec 2022——$-3M$-5M—

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-16M——$-11779.12—
Dec 2024$-10M$0M$-10M——
Dec 2023$-8M——$-8.92—
Dec 2022$-2M——$-0.13—

Quarterly results

USD · three months to · source: SEC filings
RevenueNet income
Three months to Sep 2024: revenue —, net income $-6M—Sep ’24Three months to Dec 2024 (from the annual report): revenue —, net income $-2M—Dec ’24Three months to Mar 2025: revenue —, net income $-5M—Mar ’25Three months to Jun 2025: revenue —, net income $-6M—Jun ’25Three months to Sep 2025: revenue —, net income $-7M—Sep ’25Three months to Dec 2025 (from the annual report): revenue —, net income $-21M—Dec ’25Three months to Mar 2026: revenue —, net income $-4M—Mar ’26Three months to Jun 2026: revenue —, net income $-5M—Jun ’26

Latest quarter to Jun 2026: revenue —, net income $-5M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Jun 2026.

SEC filings

Official filings of CDT Equity Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
—
Operating income
$-37 M
Net income
$-39 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$6 M
Total liabilities
$13 M
Total equity
$-7 M

As of December-2025

Top 2 institutional investors in CDT Equity Inc.#

As of Sep 30, 2026
2 institutions held 12,057 shares (about 0.2% of the shares outstanding) on Sep 30, 2026. Source: SEC Form 13F filings, filed through Nov 16, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 2 largest institutional investors in CDT Equity Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1StoneX Group Inc.11,952New0.19%$0 MNov 3, 2026
2Tower Research Capital LLC (TRC)105New0.00%$0 MNov 16, 2026

Insider trading at CDT Equity Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$7 K
5 sales, 2 insiders
Net, 12 months
-$7 K
open market only
Insiders on file
12
since
-$616 K$0Jul 2024: bought $0 (0 trades), sold $616 K (10 trades)Jul 24Sep 2024: bought $0 (0 trades), sold $122 K (1 trades)SepOct 2024: bought $0 (0 trades), sold $552 K (5 trades)OctJun 2026: bought $0 (0 trades), sold $7 K (4 trades)JunAug 2026: bought $0 (0 trades), sold $0 (1 trades)Aug
Bought (open market)Sold (open market)Hover a month for the totals
CDT Equity Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Andrew Regan10% ownerOther+499,616——499,618Form 4
filed Andrew Regan10% ownerOtherindirect+1.35 M——1.35 MForm 4
filed Andrew ReganChief Executive Officer, Director, 10% ownerOtherindirect · amended+543,683——569,322Form 4/A
filed Andrew ReganChief Executive Officer, Director, 10% ownerSellindirect · amended-29——569,322Form 4/A
filed Andrew ReganChief Executive Officer, DirectorOtherindirect+5.44 M——5.69 MForm 4
filed Andrew ReganChief Executive Officer, DirectorSellindirect-290——5.69 MForm 4
filed Prospect Capital Securities Ltd10% ownerSellindirect-5,000$0.710$4 K1.46 MForm 4
filed Prospect Capital Securities Ltd10% ownerSellindirect-1.46 M$1.440—0Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: CDT Equity Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
116,825
1 days to cover
Buybacks, Q2 2023
$0.2M
Q2 2023
Reg SHO threshold list
12 days
in the last 90 days
Shares sold short, last 24 reportsAll stocks →
CDT Equity Inc. share buybacks by quarter
Buybacks, quarterFiscalSpent
Q2 2023Q2 2023$0.2M
Q1 2023Q1 2023$113.8M

Trading halts

  • 2026-11-06 14:38 UTC, code LUDP, resumed 14:43 UTC
  • 2026-11-06 00:50 UTC, code T3, resumed 14:00 UTC
  • 2026-09-28 23:50 UTC, code T3, resumed 13:00 UTC
  • 2026-07-17 23:50 UTC, code T3, resumed 13:00 UTC
  • 2026-06-18 17:00 UTC, code LUDP, resumed 17:05 UTC

Fails to deliver

  • : 57,457 shares at $0.08
  • : 98,166 shares at $0.08
  • : 50,151 shares at $0.08
  • : 22,943 shares at $0.19
  • : 106,746 shares at $0.24

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

CDT Equity Inc. scorecard#

Passes 1 of the 8 checks that could be worked out. Fiscal year 2025; market cap of Oct 30, 2026.

  • Valuation0 of 3
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✗Price to book below its peers' medianNo price to bookShareholders' equity is negative.
    • –Price to sales below its peers' medianNo Price to sales on file.
    • –Free cash flow yield above 5%No free cash flow yield on file.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growthnot known
    • –Revenue grew in the newest yearRevenue of the year before is not on file.
    • –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
    • –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
    • –Earnings per share grew in the newest yearEarnings per share of two years are not on file.
    • –Net income higher than five years earlierNet income of five years earlier is not on file.
    • –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
  • Profitability0 of 1
    • ✗Profitable in the newest year-$39 MNet income -$39 M in fiscal 2025.
    • –Profitable in each of the last five yearsFive years of net income are not on file.
    • –Operating margin above its peers' medianNo operating margin on file.
    • –Return on equity above 15%No return on equity (equity missing or negative).
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial health0 of 3
    • ✗Short-term assets cover short-term liabilities0.3×Current ratio 0.34 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • ✗Operating income covers interest five times-183.8×Operating income -183.8 times interest in fiscal 2025.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returns1 of 1
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • –Share count up no more than 2% in a yearShare counts of two years are not on file.
    • ✓Dividends and buybacks above 3% of the market value73.3%Dividends and buybacks were 73.3% of the market value.
    • –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.

Worked out from the statements as filed (sec), the medians of Biotechnology, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

CDT Equity Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

CDT Equity Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022
Income statement
Research and development5,0543,3789037
General and administrative31,70312,0415,1723,049r
Operating expenses36,75715,4195,2623,160
Operating income−36,757−15,419−5,262−3,160r
Interest and finance income——151,976
Interest expense and finance costs20032r0100
Other non-operating income (expense)−2,467−2,3834,727−1,727r
Income before tax−39,224−17,802−536774
Income tax———375
Net income attributable to shareholders−39,224−17,802−535−4,887r
Earnings per share, basic-1,177.89-61,598.62r-0.79r-0.13
Earnings per share, diluted-1,177.89-61,598.62r-8.92r-0.13
Shares, weighted average (basic)0.00.0r0.7r37
Shares, weighted average (diluted)0.00.0r0.7r37
Balance sheet
Cash and cash equivalents1,5095544,228346
Short-term investments—600r4,200—
Other current assets1,8231,781r1,505—
Current assets4,3792,7155,733647
Property, plant and equipment26940——
Right-of-use (leased) assets142263——
Other intangible assets———5.0
Total assets5,6504,1937,2245.0r
Accounts payable1,9131,428215—
Current liabilities12,82010,7411,8014,176r
Lease liabilities (non-current)—107——
Total liabilities12,82010,9867,68110,094r
Retained earnings−68,325−29,101−11,299−10,770r
Shareholders' equity−7,170−6,793−457−10,089r
Total liabilities and equity5,6504,1937,2245.0r
Shares outstanding0.0r0.0r0.7r65
Cash-flow statement
Share-based compensation2,1831,632199—
Cash from operating activities−15,555−9,682−7,725−2,266r
Capital expenditure—−51——
Cash from investing activities−808−43725−183r
Shares issued19,6993,328150—
Shares bought back−106———
Cash from financing activities17,4226,06710,9292,448r
Change in cash955−3,6744,228297
Report10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Jun 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

Events at CDT Equity Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

Warning signs in the last three years

  • Auditor changedFiling
  • Delisting noticeFiling

Delisting notice 1 · Auditor changed 1 · Acquisition or sale completed 2 · Directors and officers 2 · Material agreement 14 · New debt 7 · Unregistered share sale 13 · Shareholder rights changed 5 · Bylaws or fiscal year changed 5 · Shareholder vote 2

CDT Equity Inc.: events reported to the SEC
FiledWhat happenedFiling
Shareholder rights changedBylaws or fiscal year changed8-K
Material agreementUnregistered share sale8-K
Material agreementNew debtUnregistered share sale8-K
Shareholder rights changedBylaws or fiscal year changed8-K
Material agreementNew debtUnregistered share sale8-K
Material agreementNew debtUnregistered share sale8-K
Directors and officersShareholder vote8-K
Acquisition or sale completed8-K/A
Material agreementNew debtUnregistered share sale8-K
Acquisition or sale completed8-K/A
Material agreementUnregistered share sale8-K
Unregistered share sale8-K
Shareholder rights changedBylaws or fiscal year changed8-K
Material agreementNew debt8-K
Auditor changed8-K
Material agreementNew debtUnregistered share sale8-K
Delisting notice8-K
Material agreement8-K
Directors and officers8-K
Shareholder rights changedBylaws or fiscal year changed8-K
Shareholder vote8-K
Material agreementNew debtUnregistered share sale8-K
Material agreementUnregistered share sale8-K
Material agreementUnregistered share sale8-K
Material agreementUnregistered share sale8-K
Material agreementUnregistered share sale8-K
Shareholder rights changedBylaws or fiscal year changed8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 4, 2026

How CDT Equity Inc. compares in Biotechnology

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
CDT Equity Inc.🇺🇸$0 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 30, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at CDT Equity Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show CDT Equity Inc.'s ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about CDT Equity Inc.? Suggest a correction